Your browser doesn't support javascript.
loading
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
Schuster, Stephen J; Huw, Ling-Yuh; Bolen, Christopher R; Maximov, Victor; Polson, Andrew G; Hatzi, Katerina; Lasater, Elisabeth A; Assouline, Sarit E; Bartlett, Nancy L; Budde, L Elizabeth; Matasar, Matthew J; Koeppen, Hartmut; Piccione, Emily C; Wilson, Deanna; Wei, Michael C; Yin, Shen; Penuel, Elicia.
Afiliação
  • Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Huw LY; Genentech, Inc., South San Francisco, CA.
  • Bolen CR; Genentech, Inc., South San Francisco, CA.
  • Maximov V; Genentech, Inc., South San Francisco, CA.
  • Polson AG; Genentech, Inc., South San Francisco, CA.
  • Hatzi K; Genentech, Inc., South San Francisco, CA.
  • Lasater EA; Genentech, Inc., South San Francisco, CA.
  • Assouline SE; Jewish General Hospital, Montreal, QC, Canada.
  • Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Budde LE; City of Hope National Medical Center, Duarte, CA.
  • Matasar MJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
  • Koeppen H; Genentech, Inc., South San Francisco, CA.
  • Piccione EC; Genentech, Inc., South San Francisco, CA.
  • Wilson D; Genentech, Inc., South San Francisco, CA.
  • Wei MC; Genentech, Inc., South San Francisco, CA.
  • Yin S; Genentech, Inc., South San Francisco, CA.
  • Penuel E; Genentech, Inc., South San Francisco, CA.
Blood ; 143(9): 822-832, 2024 Feb 29.
Article em En | MEDLINE | ID: mdl-38048694
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article